MESA Correspondents bring you cutting-edge coverage from the virtual ASTMH 2020 Annual Meeting
Day 4: Sunday, 18th November 2020
On Wednesday, November 18th, the MESA Correspondents reported from the following sessions:
- Symposium #65: Ivermectin and Antimalarial Mass Drug Administration for Malaria Control and Elimination: Preliminary Field Trial Results and Trial Designs Speakers: Umberto D’Alessandro, Brian D. Foy and Kevin C. Kobylinski.
- Symposium #66: Lessons from the National Malaria Elimination Program in China Speakers: Xiao-Nong Zhou, Ying Liu, Kay Thwe Han and Prosper Pius Chaki.
- Symposium #83: Monoclonal Antibodies to Prevent Malaria Infection and Transmission – From Antibody Identification to Clinical Evaluation Speakers: Joshua Tan, Robert Seder, Camila Coelho and Saskia C. van der Boor.
- Symposium #84: Towards Regional Elimination of Malaria in Central America Speakers: Blanca Escribano, Carlos Miranda, Alejandra Acuña Navarro and Emma Margarita Iriarte.
- Symposium #85: Host-Directed Therapeutics for Malaria Speakers: Alexis Kaushansky, Emily Derbyshire, Joseph Smith and Kevin Kain.
- Symposium #86: Severe Malaria: Improving the Continuum of Care Speakers: John Phuka, José Martins, Anitta R. Kamara and Mauricette Andriamananjara Nambinisoa
- Symposium #104: Accelerating New Tools for Radical Cure of vivax Malaria from Clinical and Operational Research to Policy Speakers: Allison L. Golden, Daniel Yilma, Michael White, Marcus Lacerda and Wint Phyo Than.
- Symposium #109: Using the Data You Have: Innovative Methods to Enhance Vector Control Evaluation and Decision-Making Speakers: Jules Mihigo, Dorothy Echodu, Ellie Sherrard-Smith and Molly L. Robertson.
Umberto D’Alessandro (MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine Disease Control & Elimination Theme, Gambia) presented his work on combined mass drug administration (MDA) of ivermectin and dihydroartemisinin-piperaquine (DHA-PQ) as a potential intervention for malaria elimination in communities in The Gambia with high coverage of other vector control interventions. One objective of this study was to evaluate the impact of ivermectin (300 µcg/kg for three days) and DHA-PQ administration on malaria transmission by tracking clinical malaria cases and using qPCR to determine malaria prevalence over two transmission seasons.
For the full report of Day 4 see pdf attached
This report is brought to you by the MESA Correspondents. Senior editorial support has been facilitated by the Organizers and Co-Chairs of the symposia, Valentina Mangano (Pisa University Hospital) and Julie Chaccour (Independent Consultant). This report is cross-posted on the MESA website and on MalariaWorld.